Currently, there is no generic version of Rexulti available [1].
When might a generic for Rexulti become available?
The patent protection for Rexulti plays a key role in determining when generic versions can enter the market. Drug patents, which grant exclusive marketing rights, typically last for 20 years from the filing date. However, various factors can influence the effective market exclusivity period, including patent term extensions and patent litigation. Information on specific patent expiry dates and ongoing legal challenges can be found on resources like DrugPatentWatch.com [2].
What is Rexulti used for?
Rexulti (brexpiprazole) is a medication prescribed to treat certain mental health conditions. It is indicated for the treatment of schizophrenia in adults and as an adjunctive treatment for major depressive disorder in adults [3].
How does brexpiprazole work?
Brexpiprazole is classified as an atypical antipsychotic. Its mechanism of action involves acting as a partial agonist at serotonin 5-HT1A and dopamine D2 receptors, and as an antagonist at serotonin 5-HT2A and noradrenergic alpha1B/2C receptors [4]. This interaction with neurotransmitter systems is believed to help manage symptoms associated with schizophrenia and depression.
Who manufactures Rexulti?
Rexulti is manufactured by Otsuka Pharmaceutical Co., Ltd. [5].
What are the common side effects of Rexulti?
Common side effects reported by patients taking Rexulti can include [3]:
* Akathisia (a feeling of restlessness)
* Weight gain
* Somnolence (drowsiness)
* Headache
* Diarrhea
* Vomiting
It is important for patients to discuss any potential side effects with their healthcare provider.
---
Sources:
[1] https://www.goodrx.com/rexulti/generic
[2] https://www.drugpatentwatch.com/
[3] https://www.rexulti.com/
[4] https://www.ncbi.nlm.nih.gov/books/NBK548429/
[5] https://www.otsuka-global.com/